Latest Breaking News On - Mick readey - Page 8 : vimarsana.com

GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdom generalUnited kingdomCity ofNick stoneMick readeySteph mountifieldJames dodwellLyndsay meyerCamilla campbellDan smithRoberto belliniLuke mielsJeff mclaughlinJosh williamsTim foley

GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal Infection

Brexafemme complements GSK’s industry-leading infectious disease portfolio with an FDA approved treatment for vulvovaginal candidiasisSCYNEXIS will receive an upfront payment of $90 million with. | March 30, 2023

United statesUnited kingdom generalUnited kingdomNew yorkCity ofJeff mclaughlinLuke mielsJames dodwellDavid anguloDan smithTim foleyCamilla campbellLyndsay meyerIrina kofflerNick stoneJosh williams

Investegate |GSK PLC Announcements | GSK PLC: Statement: Zantac (ranitidine) litigation

Investegate |GSK PLC Announcements | GSK PLC: Statement: Zantac (ranitidine) litigation
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesUnited kingdom generalCity ofJosh williamsJeff mclaughlinCamilla campbellSteph mountifieldNick stoneTim foleyLyndsay meyerJames dodwellMick readeyDan smithKathleen quinnLondon united

Investegate |GSK PLC Announcements | GSK PLC: ViiV Healthcare announces Cabenuva positive data

Investegate announcements from GSK PLC, ViiV Healthcare announces Cabenuva positive data

United kingdomUnited statesNorth carolinaCity ofUnited kingdom generalDan smithKathleen quinnCamilla campbellJosh williamsJeff mclaughlinMick readeyAudrey abernathyLyndsay meyerShionogibecamea viiTim foleyJames dodwell

ViiV Healthcare Announces Positive Data Demonstrating Long-acting Injectable Cabenuva (cabotegravir, rilpivirine) is as Effective as Daily Oral Biktarvy (BIC/FTC/TAF) for the Treatment of HIV-1

12-month findings from the SOLAR study showed that the every-two-month regimen of CAB+RPV LA demonstrated non-inferior efficacy compared to continuation of daily oral BIC/FTC/TAF 90% of participants

United kingdomUnited statesNorth carolinaCity ofUnited kingdom generalDennis riedlDan smithKathleen quinnCamilla campbellJosh williamsJeff mclaughlinMick readeyAudrey abernathyLyndsay meyerTim foleyJames dodwell